Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Net Asset Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited net asset quality index. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Net Asset Quality Index of 46.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €89.76 Billion minus total liabilities of €47.87 Billion yields net assets of €41.89 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Guangzhou Baiyunshan Pharmaceutical Hold (GU5) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Net asset quality index of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 46.7%, representing net assets of €41.89 Billion against total assets of €89.76 Billion EUR. Check strategic asset allocation of Guangzhou Baiyunshan Pharmaceutical Hold to assess the company's strategic physical and investment asset allocation.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Net Asset Quality Index by Year (2013–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see GU5 company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 47.4% | €40.08 Billion | €84.51 Billion | €44.43 Billion | ▲ +1.2 pp |
| 2024 | 46.2% | €37.77 Billion | €81.68 Billion | €43.91 Billion | ▼ -0.4 pp |
| 2023 | 46.7% | €36.68 Billion | €78.59 Billion | €41.91 Billion | ▲ +1.6 pp |
| 2022 | 45.1% | €33.64 Billion | €74.67 Billion | €41.03 Billion | ▼ -2.3 pp |
| 2021 | 47.4% | €31.33 Billion | €66.12 Billion | €34.79 Billion | ▲ +0.2 pp |
| 2020 | 47.2% | €28.21 Billion | €59.76 Billion | €31.55 Billion | ▲ +1.5 pp |
| 2019 | 45.7% | €25.99 Billion | €56.89 Billion | €30.90 Billion | ▲ +0.7 pp |
| 2018 | 45.0% | €23.14 Billion | €51.48 Billion | €28.34 Billion | ▼ -23.1 pp |
| 2017 | 68.0% | €19.26 Billion | €28.31 Billion | €9.05 Billion | ▼ -0.1 pp |
| 2016 | 68.2% | €17.65 Billion | €25.90 Billion | €8.24 Billion | ▲ +13.5 pp |
| 2015 | 54.7% | €8.68 Billion | €15.87 Billion | €7.19 Billion | ▼ -0.8 pp |
| 2014 | 55.5% | €7.92 Billion | €14.27 Billion | €6.34 Billion | ▼ -1.8 pp |
| 2013 | 57.3% | €7.02 Billion | €12.25 Billion | €5.23 Billion | — |